{"doi":"10.1002/chem.202201898","title":"Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis","abstract":"<jats:title>Abstract</jats:title><jats:p>A series of NHC‐based selenourea Ag(I) and Au(I) complexes were evaluated for their anticancer potential in vitro, on 2D and 3D human cancer cell systems. All NHC‐based selenourea complexes possess an outstanding cytotoxic potency, which was comparable or even better than that of the reference metallodrug auranofin, and were also able to overcome both platinum‐based and multi‐drug resistances. Intriguingly, their cytotoxic potency did not correlate with solution stability, partition coefficient or cellular uptake. On the other hand, mechanistic studies in cancer cells revealed their ability to strongly and selectively inhibit the redox‐regulating enzyme Thioredoxin Reductase (TrxR), being even more effective than auranofin, a well‐known TrxR inhibitor, without affecting other redox enzymes such as Glutathione Reductase (GR). The inhibition of TrxR in H157 human cancer cells caused, in turn, the disruption of cellular thiol‐redox homeostasis and of mitochondria pathophysiology, ultimately leading to cancer cell death through apoptosis.</jats:p>","journal":"Chemistry – A European Journal","year":2022,"id":639963,"datarank":0.40620753016533157,"base_score":2.70805020110221,"endowment":2.70805020110221,"self_citation_contribution":0.40620753016533157,"citation_network_contribution":0.0,"self_endowment_contribution":0.40620753016533157,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":14,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1663072,"name":"Marina Saab","orcid":null,"position":1,"is_corresponding":false},{"id":1663073,"name":"Marina Porchia","orcid":null,"position":2,"is_corresponding":false},{"id":197527,"name":"Cristina Marzano","orcid":null,"position":3,"is_corresponding":false},{"id":298981,"name":"Steven P. Nolan","orcid":"0000-0001-9024-2035","position":4,"is_corresponding":false},{"id":298978,"name":"Fady Nahra","orcid":"0000-0002-1115-9725","position":5,"is_corresponding":false},{"id":373372,"name":"Kristof Van Hecke","orcid":"0000-0002-2455-8856","position":6,"is_corresponding":false},{"id":617710,"name":"Valentina Gandin","orcid":"0000-0003-2627-1303","position":7,"is_corresponding":false},{"id":1663071,"name":"Michele De Franco","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis","abstract":"<jats:title>Abstract</jats:title><jats:p>A series of NHC‐based selenourea Ag(I) and Au(I) complexes were evaluated for their anticancer potential in vitro, on 2D and 3D human cancer cell systems. All NHC‐based selenourea complexes possess an outstanding cytotoxic potency, which was comparable or even better than that of the reference metallodrug auranofin, and were also able to overcome both platinum‐based and multi‐drug resistances. Intriguingly, their cytotoxic potency did not correlate with solution stability, partition coefficient or cellular uptake. On the other hand, mechanistic studies in cancer cells revealed their ability to strongly and selectively inhibit the redox‐regulating enzyme Thioredoxin Reductase (TrxR), being even more effective than auranofin, a well‐known TrxR inhibitor, without affecting other redox enzymes such as Glutathione Reductase (GR). The inhibition of TrxR in H157 human cancer cells caused, in turn, the disruption of cellular thiol‐redox homeostasis and of mitochondria pathophysiology, ultimately leading to cancer cell death through apoptosis.</jats:p>","is_dataset_classified":null,"base_score":2.639057329615259,"endowment":2.639057329615259,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36106679","pmcid":"PMC10092581","openalex_id":"https://openalex.org/W4295899048","authors":[],"funders":[{"funder_name":"Ministero dell’Istruzione, dell’Università e della Ricerca","grant_id":"PRIN 2017E84AA4","title":null},{"funder_name":"Universitair Ziekenhuis Gent","grant_id":"01N03217; 01CD1821","title":null},{"funder_name":"Ministero dell'Istruzione dell'Università e della Ricerca","grant_id":"unidentified","title":"unidentified"}],"total_grants":3,"fwci":1.0229,"citation_percentile":0.78016643,"influential_citations":0,"citation_trend":[{"year":2022,"count":1},{"year":2023,"count":3},{"year":2024,"count":2},{"year":2025,"count":5},{"year":2026,"count":2}],"oa_status":"hybrid","license":"cc-by-nc-nd","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/chem.202201898","host_type":"journal"},{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/chem.202201898","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/chem.202201898","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/chem.202201898","host_type":"publisher"},{"url":"https://chemistry-europe.onlinelibrary.wiley.com/doi/pdf/10.1002/chem.202201898","host_type":"publisher"},{"url":"https://doi.org/10.1002/chem.202201898","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36106679","host_type":"repository"},{"url":"https://biblio.ugent.be/publication/01GT91FPK5GK87H0P4H1X4AMG3","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10092581","host_type":"repository"},{"url":"https://hdl.handle.net/11577/3470447","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10092581/pdf/CHEM-28-0.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC10092581","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC10092581?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1002/chem.202201898","host_type":""},{"url":"https://dx.doi.org/10.1002/chem.202201898","host_type":""},{"url":"http://www.cnr.it/prodotto/i/472758","host_type":""},{"url":"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/chem.202201898","host_type":""},{"url":"https://publications.cnr.it/doc/472758","host_type":""},{"url":"https://hdl.handle.net/20.500.14243/418903","host_type":""},{"url":"http://hdl.handle.net/1854/LU-01GT91FPK5GK87H0P4H1X4AMG3","host_type":""},{"url":"http://doi.org/10.1002/chem.202201898","host_type":""},{"url":"https://biblio.ugent.be/publication/01GT91FPK5GK87H0P4H1X4AMG3/file/01GT91GYE3WRKAGS98Z20RZ0B9","host_type":""}],"fields_of_study":["Metal complexes synthesis and properties","Redox biology and oxidative stress","Synthesis and Biological Evaluation","0301 basic medicine","03 medical and health sciences","0303 health sciences","Humans","Thioredoxin-Disulfide Reductase","Gold","Silver","Auranofin","Antineoplastic Agents","Neoplasms","Oxidation-Reduction","Homeostasis","Cell Line, Tumor","Urea","Organoselenium Compounds"],"mesh_terms":["Antineoplastic Agents","Auranofin","Gold","Homeostasis","Humans","Neoplasms","Oxidation-Reduction","Silver","Thioredoxin-Disulfide Reductase","Urea","Organoselenium Compounds","Cell Line, Tumor"],"keywords":["Auranofin","Thioredoxin reductase","Chemistry","Cancer cell","Apoptosis","Cytotoxicity","Glutathione","Thioredoxin","Biochemistry","Cytotoxic T cell","Cell biology","Enzyme","Cancer research","In vitro","Cancer","Biology","Immunology","Gold(i) Complexes","Silver(i) Complexes","Trxr Inhibition","Thioredoxin-Disulfide Reductase","Silver","INHIBITION","Antineoplastic Agents","anticancer agents","gold complexes","TrxR inhibition; cytotoxicity; gold(I) complexes; silver(I) complexes","Neoplasms","Cell Line, Tumor","Organoselenium Compounds","Humans","Homeostasis","Urea","silver complexes","selenourea","Research Articles","IN-VITRO","SELENOPROTEINS","HETEROCYCLIC CARBENE COMPLEXES","THIOREDOXIN REDUCTASES","Gold","Oxidation-Reduction"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-07T05:09:01.157810Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}